Ranbaxy Gets USFDA Approval For Doxycycline Tablets

by Medindia Content Team on June 2, 2006 at 4:09 PM Drug News

Email

Print This Page

Comment

bookmark

Font : A-A+

Ranbaxy Gets USFDA Approval For Doxycycline Tablets

Ranbaxy Laboratories Ltd has received approval from USFDA for manufacturing and marketing Doxycycline Tablets in the US market.

The company informed the Bombay Stock Exchange that it got the approval for marketing the antibiotic in strengths of 50mg, 75mg and 100mg.

Doxycycline is indicated for a variety of infections caused by susceptible strains or micro-organisms including respiratory tract and urinary tract infections, skin and skin structure infections, it added.

The USFDA's office of Generic Drugs, has determined the company's formulations to be bioequivalent and having the same therapeutic effect as that of the branded drug Adoxa, marketed by Bioglan Pharmaceutical Co, Ranbaxy added.

Source:PTI News

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.

Notify me when reply is posted
I agree to the terms and conditions

Advertisement

Recommended Reading

Q Fever

Q Fever takes its origin from word “query” and is caused by bacteria Coxiella burnetii that infects some animals and is passed on to humans due to inhalation of infected air particles.

More News on:

Q Fever

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Find a Doctor

What's New on Medindia

Test Your Knowledge on Rabies

Test Your Knowledge on Rabies

Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...

Pneumonitis

Pneumonitis

Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...

Fremanezumab-vfrm For Migraine Prevention

Fremanezumab-vfrm For Migraine Prevention

Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...

View All

News Category

Supreme Court Permits Sale of Saridon, Two Other Drugs for Now Aspirin Unlikely to Benefit Older People Drug Targets for Treating Brain-eating Amoeba Infections Are We Taking Meds on Time to Suit Our Body's Internal Clock? New Nanoparticle Technology Can Help Fight Sepsis

News Archive

Date:
Category:
Keyword:

RapidSSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2018

This site complies with the HONcode standard for trustworthy health information:
verify here.